YYYukio Yoshioka

Yukio Yoshioka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yukio Yoshioka has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Naoya Kakimoto

    Department of Oral and Maxillofacial Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan

    5 shared publications
  • Hideo Shigeishi

    Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    4 shared publications
  • Hiromi Nishi

    Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan

    4 shared publications
  • Kouji Ohta

    Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    4 shared publications
  • Masaru Konishi

    Department of Oral and Maxillofacial Radiology, Hiroshima University Hospital, Hiroshima, Japan

    4 shared publications
  • Shigeaki Toratani

    Department of Molecular Oral Medicine and Maxillofacial Surgery Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan

    4 shared publications

Latest Publications

  • Open Access

    Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study

    by Hiromi Nishi, Susumu Horikoshi, Kouji Ohta, Tetsumi Yoshida, Noriyasu Fukushima, Kyoko Oshita, Syuichi Munenaga, Taro Edahiro, Hiroshi Ureshino, Hideo Shigeishi, et al.

    Oral mucositis significantly affects the quality of life in hematologic cancer patients undergoing hematopoietic stem cell transplantation. Despite global evidence supporting the efficacy of low-level laser therapy (LLLT) for mucositis prevention, its clinical adoption in Japan is limited. This study aimed to fill this gap by evaluating the safety and efficacy of LLLT in a Japanese patient population. In a single-group, non-blinded, exploratory trial, we compared 21 LLLT-treated patients against a historical control of 96 patients. The primary endpoint was the incidence of Grade ≥ 2 mucositis, based on NCI-CTCAE ver. 4.0. The LLLT group showed a significantly lower incidence of Grade ≥ 2 mucositis (23.8%) compared to the control group (64.6%) (p = 0.0006). Furthermore, Grade ≥ 2 mucositis correlated with increased oral dryness and longer hospital stays. Our study confirms the efficacy of LLLT in reducing the onset of severe oral mucositis among Japanese hematologic cancer patients, advocating for its clinical introduction as a preventive measure in Japan.


  • Open Access

    Head and neck cancer patients show poor oral health as compared to those with other types of cancer

    by Hiromi Nishi, Taiji Obayashi, Tsutomu Ueda, Kouji Ohta, Hideo Shigeishi, Syuichi Munenaga, Takashi Kono, Yukio Yoshioka, Masaru Konishi, Ryotaro Taga, et al.

    Purpose: Several studies have found associations between periodontitis and various types of cancer. Since the site of head and neck cancer (HNC) has contiguity or proximity to the oral cavity, it may be particularly influenced by oral inflammation. This study aimed to determine whether HNC patients have poor oral health as compared to those with other types of cancer. Methods: This study retrospectively examined oral environmental factors including periodontal inflamed surface area (PISA), a new periodontal inflammatory parameter. A total of 1030 cancer patients were divided into the HNC (n = 142) and other cancer (n = 888) groups. Furthermore, the HNC group was divided into high (n = 71) and low (n = 71) PISA subgroups, and independent risk factors affecting a high PISA value were investigated. Results: Multivariate logistic regression analysis showed that number of missing teeth (odds ratio 1.72, 95% CI 1.15–2.56, P < 0.01), PISA (odds ratio 1.06, 95% CI 1.03–1.06, P < 0.05), and oral bacterial count (odds ratio 1.02, 95% CI 1.01–1.03, P < 0.01) were independent factors related to HNC. In addition, multivariate logistic regression analysis indicated that current smoker (odds ratio 7.51, 95% CI 1.63–34.71, P < 0.01) and presence of untreated dental caries (odds ratio 3.33, 95% CI 1.23–9.00, P < 0.05) were independent risk factors affecting high PISA values in HNC patients. Conclusion: HNC patients have higher levels of gingival inflammation and poor oral health as compared to patients with other types of cancer, indicating that prompt oral assessment and an effective oral hygiene management plan are needed at the time of HNC diagnosis.


  • Oral surgery under general anesthesia in a patient with catecholaminergic polymorphic ventricular tachycardia: A case report

    by Sachiko Yamasaki, Yukio Yoshioka, Kana Oue, Koichi Koizumi, Souichi Yanamoto

    Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a fatal arrhythmic disease. Herein, we report a case of third molar extraction performed under general anesthesia to avoid ventricular tachycardia.Case Presentation: A 28‐year‐old woman presented with constant pain and bilateral mandibular gingival swelling. The patient had a history of CPVT diagnosis at 5 years of age, which had been managed with beta‐blockers and sodium channel blockers. Due to the contraindication of using epinephrine and the risk of CPVT induction due to pain, the extraction was conducted under general anesthesia.Conclusion: Oral surgery in CPVT patients requires appropriate anesthetic agent selection.


  • Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer

    by Katsumaro Kubo, Daisuke Kawahara, Yuji Murakami, Yuki Takeuchi, Tsuyoshi Katsuta, Nobuki Imano, Ikuno Nishibuchi, Akito Saito, Masaru Konishi, Naoya Kakimoto, et al.


  • Open Access

    Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy

    by Hiromi Nishi, Kouji Ohta, Yuri Kuramoto, Hideo Shigeishi, Taiji Obayashi, Yukio Yoshioka, Masaru Konishi, Shuichi Munenaga, Hisao Nagoshi, Tetsumi Yoshida, et al.

    Febrile neutropenia (FN) is an infectious complication that develops during chemotherapy. Although the oral cavity can be an important infection route, it is unknown whether the oral environment is associated with FN. The present study examined the relationship between the oral environment using periodontal inflamed surface area (PISA), a new periodontal disease parameter, and FN in hematologic cancer patients undergoing chemotherapy. In this retrospective cohort study, 157 patients were divided into FN onset during chemotherapy (n = 75) and the FN negative groups (n = 82). The associations of risk factors related to the intraoral environment were assessed. Logistic regression analysis showed that types of blood cancer (odds ratio 1.98; P < 0.01), use of a high-risk regimen (odds ratio 4.44; P < 0.05), prophylaxis treatment with human granulocyte colony-stimulating factor (G-CSF) (odds ratio 4.15; P < 0.01) and PISA (odds ratio 1.02; P < 0.01) were independent factors associated with FN onset. Finally, propensity score matching was performed between two groups; 37 matched pairs were generated. PISA was significantly higher in the FN group than the FN negative group. There was a significant relationship between PISA and FN onset (P = 0.035). The present findings indicate that periodontitis treatment before starting cancer treatment is recommended as supportive care for preventing FN onset during chemotherapy.


  • Open Access

    Impact of Maximum Tongue Pressure in Patients with Jaw Deformities Who Underwent Orthognathic Surgery

    by Koichi Koizumi, Tomoaki Shintani, Yuki Yoshimi, Mirai Higaki, Ryo Kunimatsu, Yukio Yoshioka, Kazuhiro Tsuga, Kotaro Tanimoto, Hideki Shiba, Shigeaki Toratani

    Malocclusion and morphological abnormalities of the jawbone often affect the stomatognathic function and long-term postoperative stability in patients with jaw deformities. There are few reports on the effect of maximum tongue pressure (MTP) in these patients. We investigated the relationship between the MTP and jawbone morphology and the effect of the MTP on surgery in 42 patients with jaw deformity who underwent surgical orthodontic treatment at Hiroshima University Hospital. The MTP was measured using a tongue pressure measurement device; the average value was considered as the MTP. Based on the MTP measured before surgery, patients were classified into the high- or the low-MTP group. The clinical findings and results of the cephalometric analysis were compared. Posterior movement of the mandible in the high-MTP group was significantly lower than that in the low-MTP group. The ANB angle, overjet, and overbite in the high-MTP group were significantly smaller than those in the low-MTP group. On the other hand, there was no difference between the two groups in the measured values, indicating a labial inclination of the anterior teeth (U1 to SN, U1 to FH, IMPA, and FMIA). MTP has been suggested to affect mandibular prognathism in patients with jaw deformities.


  • Nivolumab monotherapy after induction chemotherapy, bioradiotherapy, and cetuximab monotherapy leading to complete remission of locoregional advanced tongue cancer: A case report

    by Yukio Yoshioka, Tomoaki Hamana, Takefumi Mishima, Ryouji Tani, Shigeaki Toratani, Tetsuji Okamoto

    Herein, we report on a 66‐year‐old woman with locoregional advanced tongue cancer. She was diagnosed with left side tongue carcinoma and achieved complete remission using nivolumab monotherapy after induction chemotherapy (IC) with docetaxel, cisplatin, and 5‐fluorouracil, followed by intensity‐modulated bioradiotherapy and cetuximab monotherapy. Following bioradiotherapy, she was administered 70 cycles of cetuximab monotherapy. Both IC and bioradiotherapy exerted antitumor effects. However, primary tumor recurrence occurred. She received nivolumab, and the recurrent lesion disappeared after 18 cycles. She has been alive and well for >5 years, showing a successful locoregional control for advanced tongue cancer during this period.


  • Clinical investigation of oral cancer in adolescent and young adult generation

    by Yukio Yoshioka, Taishi Sakaue, Kensaku Matsui, Koji Tsushima, Fumitaka Obayashi, Atsuko Hamada, Sachiko Yamasaki, Tomoaki Hamana, Kensaku Sumi, Taku Kanda, et al.

    Purpose: To determine the clinical and therapeutic characteristics in adolescent and young adult (AYA) generation with oral cancer.Methods: We retrospectively studied AYA patients with oral cancer, aged 16‐40 years who visited our department between 1 April 1997 and 31 December 2017, focusing on clinical characteristics including sex, age distribution, tumor site, pathological classification, stage, treatment, treatment outcome, and social rehabilitation.Results: Forty‐two patients of AYA generation (19 males and 23 females), accounting for five. Seven percent of all oral cancer patients (740), were included. Most were aged 35‐39 (median, 30.9) years. The most frequent site of tumor occurrence was the tongue (n = 29) and the most common histological type was squamous cell carcinoma (n = 30). Most patients had T2N0 cancer based on the TNM classification, and early stage II. Thirty‐nine patients underwent radical treatment, comprising 14 cases of surgery, six of chemo‐radiation therapy, four of surgery with chemotherapy, and two of surgery with radiation therapy. Conversely, nine patients underwent radical radiation therapy, comprising five cases of internal radiation therapy and four of chemo‐radiation therapy. The 5‐year overall survival rate in AYA patients with oral cancer (79.67%) was statistically superior to that in the older‐age group (68.48%) (P = .034). Seven deaths were reported because of distant metastasis in cancer types with relatively poor prognosis.Conclusion: In this clinical investigation, treatment outcomes of AYA patients were mostly favorable. Most AYA patients with oral cancer recovered fully after radical treatment and achieved social reintegration.


  • Effects of perioperative oral care on postoperative inflammation following heart valve surgery

    by Hiromi Nishi, Shinya Takahashi, Kouji Ohta, Megumi Takamoto, Hideo Shigeishi, Seimei Go, Taiji Obayashi, Yukio Yoshioka, Masaru Konishi, Yoshitaka Shimizu, et al.

    Objective Whether oral health care during the perioperative period can lead to a better outcome after heart valve surgery has not been adequately elucidated. We examined the effects of perioperative oral care on postoperative inflammation response in patients who underwent heart valve surgery. Materials and Methods In this retrospective cohort study, 223 patients scheduled for single valve heart surgery were divided into the oral care, who underwent professional teeth cleaning or scaling within 3 days prior to surgery, and also following surgery at least twice a week (n=111), and non‐oral care (n=112) groups. After propensity score‐matching, records of both groups (80:80) were examined after surgery to evaluate inflammation markers [white blood cell count (WBC), neutrophil/white blood cell ratio (NWR), C‐reactive protein (CRP) level, body temperature (BT)]. Results WBC, NWR, CRP level, and BT were increased in both groups the day following surgery. Thereafter, CRP level, WBC, NWR, and BT on various days after surgery in the oral care group showed greater decreases as compared to the non‐oral care group. Conclusions Perioperative oral health care can decrease postoperative inflammation in patients undergoing heart valve surgery and may be important to ensure a better outcome in those patients.


  • Open Access

    Reconstruction of an upper lip and intraoral defect following resection of an upper lip melanoma using a lower lip musculomucosal flap combined with a tongue flap

    by Yukio Yoshioka, Yasutaka Hayashido, Yoku Ito, Shigeaki Toratani, Tetsuji Okamoto

    Restoring the cosmetic and functional aspects of the lip after tumor resection is challenging. We report a case of reconstruction for a defect due to resection of a melanoma using a lower lip musculomucosal flap combined with a tongue flap. A 20-year-old man was referred to our hospital and diagnosed with malignant melanoma with metastatic right submaxillary lymph nodes. We excised the tumor with neck dissection. We excised not only the right upper lip mucosa but also the gum, including some orbicularis oris muscle and alveolar bone from the right canine tooth to the left central incisor tooth. The defect was simultaneously reconstructed using both, a lower lip musculomucosal flap and a tongue flap. Revisional operation to remove contraction of a postoperative scar and the right vermillion border collection was performed at 3 months after the initial operation. There had been no functional and cosmetic trouble of the upper lip.